These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9051292)

  • 1. Inhibition by rapamycin of ornithine decarboxylase and epithelial cell proliferation in intestinal IEC-6 cells in culture.
    Seidel ER; Ragan VL
    Br J Pharmacol; 1997 Feb; 120(4):571-4. PubMed ID: 9051292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ornithine decarboxylase activity but not expression of the gene by cimetidine in intestinal mucosal cells.
    Wang JY; McCormack SA; Viar MJ; Johnson LR
    J Pharmacol Exp Ther; 1995 Jul; 274(1):521-9. PubMed ID: 7616440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-IgM-induced growth inhibition and apoptosis are independent of ornithine decarboxylase in Ramos cells.
    Lin CK; Zou HY; Kaptein JS; Yen CF; Kalunta CI; Nguyen TT; Park E; Lad PM
    Exp Cell Res; 1997 Nov; 237(1):231-41. PubMed ID: 9417887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidylinositol 3-kinase is required for the induction of ornithine decarboxylase in leukemia cells stimulated to growth.
    Flamigni F; Marmiroli S; Capanni C; Stefanelli C; Guarnieri C; Caldarera CM
    Biochem Biophys Res Commun; 1997 Oct; 239(3):729-33. PubMed ID: 9367837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrin induces phosphorylation of eIF4E binding protein 1 and translation initiation of ornithine decarboxylase mRNA.
    Pyronnet S; Gingras AC; Bouisson M; Kowalski-Chauvel A; Seva C; Vaysse N; Sonenberg N; Pradayrol L
    Oncogene; 1998 Apr; 16(17):2219-27. PubMed ID: 9619831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine A blockade of the induction of ornithine decarboxylase activity as a cause of failure of islet cell proliferation and differentiation.
    Hornby L; Metrakos P; Rosenberg L
    Clin Invest Med; 1994 Dec; 17(6):563-9. PubMed ID: 7895420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line.
    Wang SC; Zeevi A; Jordan ML; Simmons RL; Tweardy DJ
    Transplant Proc; 1991 Dec; 23(6):2920-2. PubMed ID: 1721312
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative and temporal analysis of the cellular interaction of FK-506 and rapamycin in T-lymphocytes.
    Dumont FJ; Kastner C; Iacovone F; Fischer PA
    J Pharmacol Exp Ther; 1994 Jan; 268(1):32-41. PubMed ID: 7507994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
    Hess DA; Bird IA; Almawi WY; Rieder MJ
    J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoblastic differentiation is enhanced by rapamycin in rat osteoblast-like osteosarcoma (ROS 17/2.8) cells.
    Ogawa T; Tokuda M; Tomizawa K; Matsui H; Itano T; Konishi R; Nagahata S; Hatase O
    Biochem Biophys Res Commun; 1998 Aug; 249(1):226-30. PubMed ID: 9705862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin inhibits spontaneous and fibroblast growth factor beta-stimulated proliferation of endothelial cells and fibroblasts.
    Akselband Y; Harding MW; Nelson PA
    Transplant Proc; 1991 Dec; 23(6):2833-6. PubMed ID: 1721292
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k.
    Jefferies HB; Fumagalli S; Dennis PB; Reinhard C; Pearson RB; Thomas G
    EMBO J; 1997 Jun; 16(12):3693-704. PubMed ID: 9218810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of ornithine decarboxylase in epithelial cells of rat intestine.
    Takahashi F; Miyamoto K; Minami H; Takeda E
    Tokushima J Exp Med; 1995 Jul; 42(1-2):11-5. PubMed ID: 7570589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular control of ornithine decarboxylase activity by its antizyme.
    Heller JS; Canellakis ES
    J Cell Physiol; 1981 May; 107(2):209-17. PubMed ID: 7251680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling.
    Hafizi S; Mordi VN; Andersson KM; Chester AH; Yacoub MH
    Vascul Pharmacol; 2004; 41(4-5):167-76. PubMed ID: 15607500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium stimulates ornithine decarboxylase activity in cultured mammalian epithelial cells.
    Langdon RC; Fleckman P; McGuire J
    J Cell Physiol; 1984 Jan; 118(1):39-44. PubMed ID: 6690450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of action of the new immunosuppressants: cyclosporin A, FK 506 and rapamycin].
    Rondeau E
    Nephrologie; 1992; 13(3):137. PubMed ID: 1379348
    [No Abstract]   [Full Text] [Related]  

  • 18. Apparent post-transcriptional modification of ornithine decarboxylase accounts for its induction in IEC-6 cells in culture.
    Seidel ER; Ginty DD
    Digestion; 1990; 46 Suppl 2():383-9. PubMed ID: 2262070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of immunosuppressive drugs (CsA, FK 506, rapamycin) on the kidney microsomal cytochrome P-450 system in the rat.
    Yoshimura R; Yoshimura N; Ohmachi T; Nakatani T; Ohyama A; Miyao Y; Yamamoto K; Kishimoto T
    Transplant Proc; 1994 Oct; 26(5):2890. PubMed ID: 7524223
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation.
    Iwata S; Sato Y; Asada M; Takagi M; Tsujimoto A; Inaba T; Yamada T; Sakamoto S; Yata J; Shimogori T; Igarashi K; Mizutani S
    Oncogene; 1999 Jan; 18(1):165-72. PubMed ID: 9926931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.